MGRX a recent IPO produces a med for erectile dysfunction without FDA approval;
They are basically selling a generic version of an approved medication and bypassing
the patent protections and betting they will fly under the regulator radar apparatus.
As might be expeted this recent nano-IPO is highlly volatile. Play with it only
if you have the requisite...
MGRX with some FDA news catalyst got a lot of action on the last session of the week.
With the pullback and overwhelming volume during the session, a continuation into
the upcoming week is entirely reasonable. ( see also the link)
MGRX had a last price of about $1.50 about a 50% retracement from the high of the day.
I will take a position at market price in...